Skip to main content
PLOS One logoLink to PLOS One
. 2022 May 4;17(5):e0266921. doi: 10.1371/journal.pone.0266921

Conversion of mammalian cell culture media waste to microbial fermentation feed efficiently supports production of recombinant protein by Escherichia coli

Ciara D Lynch 1,2, David J O’Connell 1,2,*
Editor: Vasu D Appanna3
PMCID: PMC9067682  PMID: 35507546

Abstract

Deriving new value from waste streams through secondary processes is a central aim of the circular bioeconomy. In this study we investigate whether chemically defined spent media (CDSM) waste from cell culture bioprocess can be recycled and used as a feed in secondary microbial fermentation to produce new recombinant protein products. Our results show that CDSM supplemented with 2% glycerol supported a specific growth rate of E. coli cultures equivalent to that achieved using a nutritionally rich microbiological media (LB). The titre of recombinant protein produced following induction in a 4-hour expression screen was approximately equivalent in the CDSM fed cultures to that of baseline, and this was maintained in a 16-hr preparative fermentation. To understand the protein production achieved in CDSM fed culture we performed a quantitative analysis of proteome changes in the E. coli using mass spectrometry. This analysis revealed significant upregulation of protein synthesis machinery enzymes and significant downregulation of carbohydrate metabolism enzymes. We conclude that spent cell culture media, which represents 100s of millions of litres of waste generated by the bioprocessing industry annually, may be valorized as a feed resource for the production of recombinant proteins in secondary microbial fermentations. Data is available via ProteomeXchange with identifier PXD026884.

Introduction

Diversion of waste streams generated by bio-industries to secondary processes to produce valuable products through microbial and chemical engineering has become a central pillar of the circular bioeconomy [1]. One example of a waste stream from bioindustry that has yet to be diverted to the creation of new valuable products is the cell culture media used in the bioprocessing of protein drug molecules. The commercial production of monoclonal antibodies using Chinese hamster ovary (CHO) cell bioprocess in 2019 alone resulted in approximately 30 metric tonnes of protein product [2]. The chemically defined cell culture media used to feed the mammalian cells is itself a sophisticated chemical formulation that also represents a significant waste product in downstream processing. The formulation of chemically defined media used to culture stable cell lines in bioprocesses has been designed to remove the need for serum addition to achieve optimal cell growth and facilitate the purification of the expressed protein [3]. The regulations surrounding the bioprocessing of therapeutic proteins for drug use requires defined media without the addition of animal ingredients that cannot be fully standardised. Additionally, stable cell line clones for the expression of commercial proteins relies on genomic integration of the target protein producing genes rather than transient expression from plasmid constructs. This removes the requirement for selective pressure with added antibiotics to maintain plasmid constructs [3].

Based on a product titre of 10 g/L of IgG in batch and fed batch systems, with the total yield of protein product produced in 2019 as a reference, we estimate that up to 300 million litres of cell culture waste is generated annually [2, 4]. Systematic approaches to valorize this waste as part of a commitment to a circular bioeconomy have not been investigated. We hypothesise that spent media from CHO cell culture has the potential to support E. coli fermentation and the production of recombinant protein titres when recycled from bioprocessing systems.

The re-use of spent media has been investigated in certain process systems, mostly through feeding spent media from the original culture as a supplement to fresh media in the same system [59]. These have reported some improvement in protein expression and growth rates. For example, IgG expression titre in mouse hybridoma cell culture was increased by as much as 50% when the cells were grown in culture media with 33% spent media supplementation [7]. Conversely, feeding the cells with 100% spent media led to a significant decrease in growth and protein production by the mammalian cells. This decrease was attributed to the build-up of auto-inhibitory metabolites and lack of nutrients.

Genetic engineering of a wide array of bacteria has been a central pillar of the development of the circular bioeconomy, enabling new product development from diverse organic waste streams including food oils, agrochemical waste and used bioplastics [1015]. We aimed to test our hypothesis using Escherichia coli, a robust and versatile bacteriological expression host that is widely used commercially to produce recombinant proteins. The production of recombinant human insulin in E. coli for example, is a major milestone in human drug production [16, 17]. E. coli has been shown to utilize breakdown metabolites such as lactate present in spent culture medias [18] and can grow successfully in spent media from the fermentation of other cell types [9].

Comparative analysis of culture growth rates of an E. coli BL21 strain harbouring a recombinant mCherry-EF2 expression construct in rich microbiological media (LB) and in chemically defined spent media (CDSM) that had previously been used to culture CHO cells, either with or without supplementation, confirmed CDSM as a viable feed for bacterial fermentation. Analysis of recombinant protein production by the cultures confirmed equivalent recombinant protein titres post-purification when compared to LB.

Results

Growth rate analysis of E. coli BL21 mCherry/EF2 in minimal media, baseline rich media and chemically defined spent media

Growth rates of E. coli cultures grown in M9 minimal media with carbon source supplementation were measured to determine the optimal supplementation conditions that could then be applied to the CDSM fed cultures. Glycerol was selected as a suitable carbon supplementation as it is also a waste product from other processes. Gradients of glycerol additions were tested at concentrations of 1%-3% (Fig 1A). 2% glycerol supplementation was shown to produce a specific growth rate of 0.673 generations per hour, as compared to the growth rates of 1% and 3% at 0.578 and 0.647.

Fig 1. E. coli culture growth rates in bacteriological and cell culture media.

Fig 1

(A). Glycerol supplementation in M9 minimal media; ■ = baseline media, ● = minimal media, ◆ = minimal media + 1% glycerol, □ = minimal media + 2% glycerol, ▲ = minimal media + 3% glycerol. (B). Unsupplemented and supplemented chemically defined spent media (CDSM). ■ = baseline media, ● = M9 media, ◇ = chemically defined spent media (CDSM) unsupplemented, □ = CDSM with 2% glycerol. All time points were completed in triplicate with standard deviation as error bars. Numerical data used to generate growth curves and standard deviations are reported in S2 Table.

The chemically defined spent medium used was CHOgro® spent media harvested from CHO (Chinese Hamster Ovary) cell culture. The specific growth rate of the E. coli in the CDSM was 0.704 gen/hour, approximately 70% of the rate achieved in the baseline LB media. Supplementing CDSM with 2% glycerol led to a further increase in growth rates to ~94% of that of LB (Fig 1B). This supplementation was chosen for all medias tested for protein expression analysis.

Protein expression analysis in chemically defined spent media fermentation

Recombinant mCherry-EF2 expression was tested in cultures grown in CDSM supplemented with 2% glycerol and the baseline LB with 2% glycerol. A four-hour expression screen post-induction with IPTG showed that protein production in CDSM was equivalent to baseline LB, with an average yield of 100.58 mg/L compared to LB’s 92.57 mg/L (Fig 2A).

Fig 2. Protein expression and purification analysis.

Fig 2

(A.) Table of growth characteristics, biomass, and protein yields. LB media; Lysogeny Broth baseline rich media. M9 media; minimal salts media. CDSM I; chemically defined spent media CHOgro®. CDSM II; chemically defined spent media Expi-CHO®. R2 coefficient is the percentage of variability in the growth curve dataset that is accounted for by linear correlation between the OD600 (nm) and the time (hr). For the equation for the specific growth rate, see Methods. * n = 2 for all standard deviation calculations. (B.) SDS-PAGE analysis of purified protein versus input supernatant sample. Lane 1 = protein marker, lane 3 = post-boil supernatant sample from CDSM, lane 5 = purified monomeric fraction from size exclusion chromatography of CDSM. Full image available as S1 Raw images.

We next tested a 16-hour expression post-induction with IPTG using CDSM, and included a second chemically defined spent medium, Expi-CHO® (termed CDSM II), to examine the robustness of our finding with widely used commercial medias. Protein yield from the CDSM I fed culture closely matched the yield of that from LB with a protein yield of 159.82 mg/L compared to 168.92 mg/L (Fig 2A). The alternate spent media type tested, CDSM II, managed a successful yield of 127.57 mg/L. It should be noted that the CDSM II condition also lost some yield during expression, seen by the presence of the recombinant protein in the extracellular media also. SDS-PAGE analysis confirmed that the monomeric peak taken from SEC corresponding to the mCherry-EF2 protein at 32 kDa.

Mass spectrometry analysis of E. coli cultures at the whole proteome level

We performed a proteomic analysis of the protein expression patterns in the bacterial cultures themselves using LC-MS/MS. The analysis of proteomic data files was carried out using MaxQuant. Using the protein expression pattern for E. coli grown in LB media as a baseline reference, a student’s t-test with a false discovery rate of <0.05 identified 655 differentially expressed proteins in E. coli cultures grown in unsupplemented CDSM. In 2% glycerol supplemented CDSM conditions there were 167 proteins differentially expressed by comparison (Fig 3).

Fig 3. Number of statistically significant differentially expressed proteins compared to the baseline condition in LB media.

Fig 3

Orange bars represent the number of downregulated proteins while blue represents all upregulated proteins compared to baseline LB media after a student’s t-test with an FDR of < 0.05.

In CDSM I supplemented with 2% glycerol, 1,222 proteins were found to be dysregulated and of these, 167 proteins were statistically significant. From these 167 proteins, 87 proteins were identified as upregulated and 80 proteins as downregulated. A program that measures the quantitative differences in expression by difference in LFQ intensity was written using Python script and using a cut-off significance value of >0.5 or <-0.5 in intensity identified the most significantly changed expression levels, shown here for the first time as a pool table plot (Fig 4). Proteins upregulated in the CDSM I + 2% glycerol condition were principally in the amino-acid and purine biosynthesis pathways, while proteins that were most significantly downregulated were in the carbohydrate metabolism pathway (Fig 4).

Fig 4. Pool-table plot of the proteomic analysis of the significantly dysregulated proteins from the sample condition of CHOgro® with 2% glycerol supplementation.

Fig 4

This graph was constructed using the Matplotlib library in Python. Significant upregulation of expression is shown to the right of the central threshold divider (-0.5 to 0.5), with significant downregulation to the left. Significance in this case was defined as having a mean difference in LFQ intensity compared to the baseline media of more than 0.5 in either direction after a student’s t-test and with an FDR of <0.05. The top three pathway proteins and the top one unannotated pathway protein are labelled directly below their representative point, for both up- and down-regulated.

Amino acid biosynthesis and purine metabolism functional pathways were up-regulated in all cultures grown in CDSM compared to the baseline. Carbohydrate metabolism by contrast was mainly downregulated. Within amino acid biosynthesis are some of the most statistically significantly upregulated enzymes, such as diaminopimelate decarboxylase and Aspartate-ammonia ligase, two enzymes that are upregulated with a mean difference of LFQ intensity of > 2, along with 10 other significantly upregulated enzymes in this pathway. Purine metabolism also features highly upregulated enzymes such as glutamine dependent amidophosphoribosyltransferase, with a difference in intensity of > 3 along with 12 other significantly upregulated enzymes.

Discussion

Can spent media from CHO cell culture be reused to feed E. coli fermentation?

The creation of chemically defined culture media has led to increasing recombinant protein titres and protein quality [19, 20]. These successful developments have resulted in this cell culture media becoming a significant waste stream with approximately 300 million litres sent for disposal annually [2].

Our data indicates that chemically defined spent media (CDSM) is a potentially valuable resource for producing new recombinant proteins when compared with microbiological media prepared with casein digests and yeast extract, such as the LB media studied here. In this study we investigated the expression of a recombinant fusion protein ligand (EF2) derived from mCherry and the calcium binding protein Calbindin D9k. This recombinant protein has been developed as a ligand for a highly specific and high affinity purification system [2124]. The growth rate of the expression culture in the CDSM + 2% glycerol reached was similar to the LB at ~94% while the 4-hour protein yield was approximately equal, a striking and unanticipated finding (Fig 2A). This finding was further verified in the 16-hour fermentation, a model of a preparative scale expression, whereby the CDSM cultures successfully supported a protein expression over this longer period with approximately the same yield (159.82 mg/L) as those cultures grown in the nutritionally rich LB media (168.92 mg/L) (Fig 2A). This finding prompted us to investigate the proteome of the cultures to identify proteins responsible for metabolic changes that may contribute to this phenotype.

Proteomic analysis

Out of the 629 upregulated proteins identified in the optimised condition of CDSM + 2% Glycerol, the most statistically significantly upregulated proteins are enzymes involved in the amino acid biosynthesis pathway. For example, both Diaminopimelate decarboxylase and Aspartate-ammonia ligase are two highly upregulated proteins with LFQ differences of > 2 (Fig 4, Table 1), involved in lysine biosynthesis and asparagine biosynthesis pathways that are dependent on glutamine uptake [25]. Glutamine (4 mM) is a supplement added to the chemically defined media prior to CHO cell culture. Amino acid accumulation such as increased L-asparagine is a known feature of the E. coli stress response, to make available the building blocks needed for synthesis of stress response proteins [26]. This upregulation may indicate the activation of a stress response in the cultures that is not activated in rich microbiological media but that contributes to recombinant protein expression. Other highly upregulated proteins (>2 fold) include glycerol metabolism enzymes such as Phosphogluconate dehydratase, purine metabolism enzymes such as glutamine dependent Amidophosphoribosyltransferase, and iron uptake proteins such as Enterobactin non-ribosomal peptide synthetase EntF, among others [2729]. Interestingly the increased expression of the glycerol metabolism enzyme Phosphogluconate dehydratase and glutamine dependent Amidophosphoribosyltransferase correlates well with the supplementation with both glycerol and glutamine and confirms the sensitivity of this MS analysis.

Table 1. Most significantly dysregulated E. coli proteins and the associated annotated functional pathway.

Proteins highlighted by accession number in Fig 4 are described here with one example of an upregulated and downregulated protein lacking an annotated functional pathway.

Uniprot Entry Protein Name Gene Pathway Description LFQ Difference
Up-regulated Proteins
A0A140NEZ0 Periplasmic copper-binding protein cusF Unannotated Homologue of Cation efflux system protein 3.59
A0A140N9W7 Amidophosphoribosyltransferase purF Purine metabolism IMP biosynthesis via de novo pathway 3.02
A0A140NAT6 Phosphogluconate dehydratase edd Carbohydrate metabolism Entner-Doudoroff pathway; catalyses glucose into pyruvate 2.89
A0A140ND59 Aspartate—ammonia ligase asnA Amino-acid biosynthesis L-asparagine biosynthesis 2.79
Down-regulated Proteins
A0A140N4R7 Protein YcfR yhcN Unannotated Homologue of Peroxide/acid stress response protein YhcN -3.24
A0A140N8U6 Phospho-2-dehydro-3-deoxyheptonate aldolase aroF Metabolic intermediate biosynthesis Member of the chorismate biosynthesis pathway -2.42
A0A140N9V4 Probable malate: quinone oxidoreductase mqo Carbohydrate metabolism Tricarboxylic acid cycle; oxaloacetate from (S)-malate -2.33
A0A140NCJ4 D-amino acid dehydrogenase dadA Amino-acid degradation D-alanine degradation -2.14

Among the 595 downregulated proteins in the CDSM + glycerol condition are enzymes involved in the TCA cycle such as the probable malate:quinone oxidoreductase, some specific stress response proteins such as protein YcfR (an acid stress response protein), and nucleotide synthesis/salvage proteins, such as cytidine deaminase. Many of these proteins depend on the presence of glucose in order to be active, leading to a possible reason for their downregulation in the CDSM + glycerol condition [30, 31]. Other downregulated proteins which are statistically significant include D-amino acid dehydrogenase, involved in amino-acid degradation, and generally present in high levels in LB rich broth due to extracellular D-amino acids which are not present in the CDSM [32, 33].

One of the main metabolic pathways that was upregulated in the CDSM media compared to LB was the amino-acid biosynthesis pathway. The baseline condition of LB contains tryptone, a source of nitrogen-containing peptides for E. coli growth, whereas the spent CHOgro® media must rely on the proteins released by the CHO cell culture conditions [34]. CHO cell growth in chemically defined media produces metabolites such as ammonium and lactate that can inhibit further growth [35]. These factors however can be used by E. coli to grow, utilising ammonium as its preferred nitrogen source and can break down lactate as a possible carbon source if needed [36]. The 102 proteins that are significantly dysregulated and are yet to be assigned a pathway on Uniprot are involved in a wide array of metabolic processes in the E. coli cell, such as the acid stress response protein seen to be the most downregulated in Table 1. Further study into these individual proteins will help to understand the proteomic adaptions undertaken by the CDSM fed E. coli.

Proteomic analysis of the nutritional content of CDSM

CHO cells generally produce approximately 1,400 host cell proteins (HCPs) which are detectable in the clarified spent culture media, with ~80% of the top 1000 of these HCPs in common across multiple cell lines [37, 38]. Mass spectrometry-based analysis has been widely employed to characterise HCP’s across a number of studies [3941].

Mass spectrometry analysis of the CDSM alone identified 879 host cell proteins from CHO in the spent media after culturing (see S1 Table). These proteins were identified from all cellular compartments suggesting they are debris from CHO cell lysis in addition to any active secretion by the growing cells. These host cell proteins represent a source of amino acid building blocks for the increased recombinant protein production capabilities of the E. coli cultures.

Conclusion

We have shown in this study that mammalian cell culture waste, the chemically defined synthetic media used to grow Chinese Hamster Ovary cells, is conditioned such that it provides a nutritious feed for the growth of E. coli cultures in secondary fermentation. The growth rate of the culture in this waste medium is similar to that of rich microbiological culture media and upon supplementation with another waste by-product, glycerol, the growth rate is enhanced. Importantly, the expression of a recombinant protein from an expression plasmid construct is seen to be equivalent in protein titre between 4 to 16 hours showing that this waste has a real value in a biotechnological context. This approach may be further developed based on a deeper understanding of the protein expression patterns analysed here, that show significant upregulation and downregulation of metabolic enzymes and pathways. This approach can begin a route for the capture of a bioprocessing waste stream for the circular bioeconomy.

Experimental procedures

Mammalian cell culture

Chinese Hamster Ovary (CHO) cells were incubated in 20 ml of serum-free CHOgro® Expression media supplemented with 4 mM L-Glutamine in T75 adherent cell line flasks, at 37˚C with 5% CO2. Cells were split at 70–80% confluency every 3–4 days. Spent media was harvested at each split and was clarified of cells and cellular debris by centrifugation at 300 x g for 4 minutes prior to storing at 4°C for up to 14 days. The pH of the spent media was generally > 7.5 post-culture and this was adjusted to pH 7 prior to use in bacterial fermentation with addition of dilute HCl. No other supplementation was added. Remaining glucose levels in the spent media after harvesting was 1.6%.

Growth and expression cultures of E. coli

E. coli BL21 Gold was transformed with an mCherry-EF2 fusion protein expression construct with a T7 promoter expression system. A 10 ml starter culture of BL21 transformed E. coli was grown by incubating a single, isolated colony in Lysogeny Broth (LB) media, 2% glucose, and 100 μg/ml ampicillin. The culture was grown in a shaking incubator at 250 rpm, 37°C for 16 hours. Growth curves were taken from 50 ml cultures grown in triplicate in 250ml flasks by measuring OD600 every half an hour for growth curve plotting until the OD600 reached 0.6. The four-hour expression was carried out in duplicate 50 ml cultures with 2% glycerol and a 1 in 20 dilution of starter culture in the expression media in a shaking incubator at 250 rpm, 37°C.Expression of the fusion protein was induced by addition of 1 mM IPTG after OD600 reached 0.6. Cultures were then incubated on a shaking incubator at 250 rpm, 30°C for 4 hours or for 16 hours for the overnight expression experiment. Cultures were then spun at 4°C, 4000 x g for 20 minutes to harvest the pellets which were weighed prior to protein purification.

Calculations of specific growth rate

k=log10[Xt]log10[X0]0.301×t

Specific growth rate (k) was calculated by the above equation, where k is generations per hour and t is time in hours. Plots of growth curves of OD600 (nm) versus time (hrs) were generated to gather this data in Excel. Xt is one OD600 value at a later position, and X0 is another OD600 value taken from an earlier position using a trendline.

Recombinant protein purification

Cell pellets were re-suspended using a buffer containing 10 mM Tris and 2 mM CaCl2 pH 7.4 before lysing by sonication. The lysate was then boiled at 85 degrees Celsius and spun at 15,000 x gfor 30 minutes. Supernatant was harvested and referred to as the post-boil (PB) sample. 0.5 ml of this PB was run on a Superdex 200 10/300 size exclusion chromatography column, using Hepes Buffer Saline as a running buffer. Protein concentration was measured with a DeNovix DS-11 Spectrophotometer, using the UV-Vis application. Measurements were taken at 585 nm for mCherry yield, with an extinction coefficient calculated at 44,854.2 M-1cm-1 and a protein molecular weight of 30,667.4 g/mol.

Proteomic analysis

4 ml of E. coli culture was harvested after reaching OD600 of 0.6, but before IPTG induction. These cultures were re-suspended in 8M urea. 5mM DTT was then added, and samples were incubated at room temperature for 10 minutes. After incubation, 10mM iodoacetamide was added, and samples were incubated in the dark for 10 minutes at room temperature. Samples were brought to neutral pH by addition of 150 μl of 200 mM NH4HCO3. Samples were then digested with trypsin at 37°C and 300 rpm on a thermomixer overnight. Samples were spun at 4000 x g for 2 mins to prevent ZipTip® from getting blocked in the next steps. Digested peptides were filtered through ZipTip® columns and eluted using 70% acetonitrile in acidic water (0.1% formic acid). The elution was dried off by speed-vac at 45°C. The dried peptides were then re-suspended in 30 μl Buffer A (5% acetonitrile and 0.1% TFA). Analysis of proteomic data files was carried out using MaxQuant [42] to assemble peptides using the E. coli BL21 proteome from Uniprot (UP000002032). The software Perseus [43] was used to analyse the resulting dataset for student’s t-tests and heatmap generation. A Python programme was generated to give the remaining graphs, using the t-test results generated from Perseus and annotation information from Uniprot for E. coli strain BL21 (available on GitHub at https://github.com/Ciara-Lynch/Mass_Spec_Analysis.git).

Supporting information

S1 Raw images. Raw gel image for SDS-PAGE.

PDF of uncropped gel image from Fig 2, panel B.

(PDF)

S1 Table. Table of CHO host cell proteins detected by LC-MS/MS in a spent CHOgro® media sample.

Completed in triplicate with mean LFQ values displayed in third column.

(XLSX)

S2 Table. Table of numerical data used to generate growth curves and standard deviations.

Completed in triplicate. Corresponds to growth curves generated for Fig 1.

(XLSX)

Acknowledgments

Thank you to Eugene Dillon and Siobhan Kelly for guidance on mass spectrometry usage.

Data Availability

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD026884. Submission details: Project Name: E. coli BL21 Gold LC-MSMS in varying growth conditions Project accession: PXD026884.

Funding Statement

CL & DO'C are funded by the centre for doctoral training, Atoms-2-Products. The A2P CDT is supported by the Science Foundation Ireland (SFI) and the Engineering and Physical Sciences Research Council (EPSRC) under Grant No. 18/EPSRC-CDT/3582. The work was also supported by the Science Foundation Ireland funded BiOrbic bioeconomy research centre under grant no. 16/RC/3889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Stegmann P, Londo M, Junginger M. The circular bioeconomy: Its elements and role in European bioeconomy clusters. Resources, Conservation & Recycling: X. 2020. May 1;6:100029. [Google Scholar]
  • 2.Ecker and Patricia Seymour D. Mammalian Biomanufacturing Industry Supply & Demand Trends [Internet]. BioProcess Online. 2020. [cited 2021 Aug 26]. Available from: https://www.bioprocessonline.com/doc/mammalian-biomanufacturing-industry-supply-demand-trends-0001. [Google Scholar]
  • 3.Ritacco FV, Wu Y, Khetan A. Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: History, key components, and optimization strategies. Biotechnol Prog. 2018. Nov;34(6):1407–26. doi: 10.1002/btpr.2706 [DOI] [PubMed] [Google Scholar]
  • 4.Kunert R, Reinhart D. Advances in recombinant antibody manufacturing. Appl Microbiol Biotechnol. 2016. Apr;100(8):3451–61. doi: 10.1007/s00253-016-7388-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Riese U, Lütkemeyer D, Heidemann R, Büntemeyer H, Lehmann J. Re-use of spent cell culture medium in pilot scale and rapid preparative purification with membrane chromatography. J Biotechnol. 1994;34: 247–257. doi: 10.1016/0168-1656(94)90060-4 [DOI] [PubMed] [Google Scholar]
  • 6.Wu J, Ruan Q, Lam HYP. Evaluation of spent medium recycle and nutrient feeding strategies for recombinant protein production in the insect cell–baculovirus process. J Biotechnol. 1998;66: 109–116. [Google Scholar]
  • 7.Ogawa A, Takada N, Terada S. Effective antibody production by reusing culture medium previously used in antibody purification. Biosci Biotechnol Biochem. 2009;73: 719–721. doi: 10.1271/bbb.80353 [DOI] [PubMed] [Google Scholar]
  • 8.Beas-Catena A, Sánchez-Mirón A, Garía-Camacho F, Contreras-Gómez A, Molina-Grima E. The effect of spent medium recycle on cell proliferation, metabolism and baculovirus production by the lepidopteran Se301 cell line infected at very low MOI. J Microbiol Biotechnol. 2013;23: 1747–1756. doi: 10.4014/jmb.1305.05067 [DOI] [PubMed] [Google Scholar]
  • 9.Yano T, Mori H, Kobayashi T, Shimizu S. Reusability of Broth Supernatant as Medium: Journal of fermentation technology. 1980;58(3):259–66. [Google Scholar]
  • 10.Guzik MW, Kenny ST, Duane GF, Casey E, Woods T, Babu RP, et al. Conversion of post consumer polyethylene to the biodegradable polymer polyhydroxyalkanoate. Appl Microbiol Biotechnol. 2014;98: 4223–4232. doi: 10.1007/s00253-013-5489-2 [DOI] [PubMed] [Google Scholar]
  • 11.Cerrone F, Davis R, Kenny ST, Woods T, O’Donovan A, Gupta VK, et al. Use of a mannitol rich ensiled grass press juice (EGPJ) as a sole carbon source for polyhydroxyalkanoates (PHAs) production through high cell density cultivation. Bioresour Technol. 2015;191: 45–52. doi: 10.1016/j.biortech.2015.04.128 [DOI] [PubMed] [Google Scholar]
  • 12.Narancic T, Verstichel S, Reddy Chaganti S, Morales-Gamez L, Kenny ST, De Wilde B, et al. Biodegradable Plastic Blends Create New Possibilities for End-of-Life Management of Plastics but They Are Not a Panacea for Plastic Pollution. Environ Sci Technol. 2018;52: 10441–10452. doi: 10.1021/acs.est.8b02963 [DOI] [PubMed] [Google Scholar]
  • 13.Gervasi T, Pellizzeri V, Calabrese G, Di Bella G, Cicero N, Dugo G. Production of single cell protein (SCP) from food and agricultural waste by using Saccharomyces cerevisiae. Nat Prod Res. 2018;32: 648–653. doi: 10.1080/14786419.2017.1332617 [DOI] [PubMed] [Google Scholar]
  • 14.Ruiz C, Kenny ST, Narancic T, Babu R, Connor KO. Conversion of waste cooking oil into medium chain polyhydroxyalkanoates in a high cell density fermentation. J Biotechnol. 2019;306: 9–15. doi: 10.1016/j.jbiotec.2019.08.020 [DOI] [PubMed] [Google Scholar]
  • 15.Rechtin TM, Hurst M, Potts T, Hestekin J, Beitle R, McLaughlin J, et al. Production of recombinant protein in Escherichia coli cultured in extract from waste product alga, Ulva lactuca. Biotechnol Prog. 2014;30: 784–789. doi: 10.1002/btpr.1924 [DOI] [PubMed] [Google Scholar]
  • 16.Kroeff EP, Owens RA, Campbell EL, Johnson RD, Marks HI. Production scale purification of biosynthetic human insulin by reversed-phase high-performance liquid chromatography. J Chromatogr. 1989. Jan 6;461:45–61. doi: 10.1016/s0021-9673(00)94274-2 . [DOI] [PubMed] [Google Scholar]
  • 17.Storrs SB, Przybycien TM: Commercial-scale refolding of recombinant methionyl bovine somatotropin. In Protein Refolding. Edited by Georgiou G, DeBernardez-Clark E. Washington, DC: American Chemical Society; 1991:197–205. [Google Scholar]
  • 18.Caglar MU, Houser JR, Barnhart CS, Boutz DR, Carroll SM, Dasgupta A, et al. The E. coli molecular phenotype under different growth conditions. Sci Rep. 2017;7: 45303. doi: 10.1038/srep45303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huang YM, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog. 2010. Sep-Oct;26(5):1400–10. doi: 10.1002/btpr.436 . [DOI] [PubMed] [Google Scholar]
  • 20.Xu J, Rehmann MS, Xu X, Huang C, Tian J, Qian NX, et al. Improving titre while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media. MAbs. 2018. Apr;10(3):488–499. doi: 10.1080/19420862.2018.1433978 Epub 2018 Feb 20. ; PMCID: PMC5916559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Berggård T, Julenius K, Ogard A, Drakenberg T, Linse S. Fragment complementation studies of protein stabilization by hydrophobic core residues. Biochemistry. 2001. Feb 6;40(5):1257–64. doi: 10.1021/bi0014812 [DOI] [PubMed] [Google Scholar]
  • 22.Dell’Orco D, Xue WF, Thulin E, Linse S. Electrostatic contributions to the kinetics and hermodynamics of protein assembly. Biophys J. 2005. Mar;88(3):1991–2002. doi: 10.1529/biophysj.104.049189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mhurchú NN, Zoubak L, McGauran G, Linse S, Yeliseev A, O’Connell DJ. Simplifying G Protein-Coupled Receptor Isolation with a Calcium-Dependent Fragment Complementation Affinity System. Biochemistry. 2018. Jul 31;57(30):4383–4390. doi: 10.1021/acs.biochem.8b00469 [DOI] [PubMed] [Google Scholar]
  • 24.McGauran G, Linse S, O’Connell DJ. Single Step Purification of Glycogen Synthase Kinase Isoforms from Small Scale Transient Expression in HEK293 Cells with a Calcium-Dependent Fragment Complementation System. Methods Mol Biol. 2020;2095:385–396. doi: 10.1007/978-1-0716-0191-4_22 [DOI] [PubMed] [Google Scholar]
  • 25.Lomelino CL, Andring JT, McKenna R, Kilberg MS. Asparagine synthetase: Function, structure, and role in disease. J Biol Chem. 2017. Dec 8;292(49):19952–19958. doi: 10.1074/jbc.R117.819060 Epub 2017 Oct 30. ; PMCID: PMC5723983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jozefczuk S, Klie S, Catchpole G, Szymanski J, Cuadros-Inostroza A, Steinhauser D, et al. Metabolomic and transcriptomic stress response of Escherichia coli. Mol Syst Biol. 2010. May 11;6:364. doi: 10.1038/msb.2010.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gardner PR, Fridovich I. Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. J Biol Chem. 1991. Jan 25;266(3):1478–83. . [PubMed] [Google Scholar]
  • 28.Gots JS, Benson CE, Jochimsen B, Koduri KR. Microbial models and regulatory elements in the control of purine metabolism. Ciba Found Symp. 1977;(48):23–41. doi: 10.1002/9780470720301.ch3 . [DOI] [PubMed] [Google Scholar]
  • 29.Messenger LJ, Zalkin H. Glutamine phosphoribosylpyrophosphate amidotransferase from Escherichia coli. Purification and properties. J Biol Chem. 1979. May 10;254(9):3382–92. . [PubMed] [Google Scholar]
  • 30.Flores N, Xiao J, Berry A, Bolivar F, Valle F. Pathway engineering for the production of aromatic compounds in Escherichia coli. Nat Biotechnol. 1996. May;14(5):620–3. doi: 10.1038/nbt0596-620 . [DOI] [PubMed] [Google Scholar]
  • 31.Van der Rest ME, Frank C, Molenaar D. Functions of the membrane-associated and cytoplasmic malate dehydrogenases in the citric acid cycle of Escherichia coli. J Bacteriol. 2000. Dec;182(24):6892–9. doi: 10.1128/JB.182.24.6892-6899.2000 ; PMCID: PMC94812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Baev MV, Baev D, Radek AJ, Campbell JW. Growth of Escherichia coli MG1655 on LB medium: monitoring utilization of amino acids, peptides, and nucleotides with transcriptional microarrays. Appl Microbiol Biotechnol. 2006. Jul;71(3):317–22. doi: 10.1007/s00253-005-0310-5 [DOI] [PubMed] [Google Scholar]
  • 33.Franklin FC, Venables WA. Biochemical, genetic, and regulatory studies of alanine catabolism in Escherichia coli K12. Mol Gen Genet. 1976. Dec 8;149(2):229–37. doi: 10.1007/BF00332894 . [DOI] [PubMed] [Google Scholar]
  • 34.Sezonov Guennadi, Joseleau-Petit Danièle, and D’Ari Richard. 2007. “Escherichia Coli Physiology in Luria-Bertani Broth.” Journal of Bacteriology 189 (23): 8746–49. doi: 10.1128/JB.01368-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pereira S, Kildegaard HF, Andersen MR. Impact of CHO Metabolism on Cell Growth and Protein Production: An Overview of Toxic and Inhibiting Metabolites and Nutrients. Biotechnol J. 2018. Mar;13(3):e1700499. doi: 10.1002/biot.201700499 [DOI] [PubMed] [Google Scholar]
  • 36.Merrick MJ, Edwards RA. Nitrogen control in bacteria. Microbiol Rev. 1995. Dec;59(4):604–22. doi: 10.1128/mr.59.4.604-622.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yuk IH, Nishihara J, Walker D Jr, Huang E, Gunawan F, Subramanian J, et al. More similar than different: Host cell protein production using three null CHO cell lines. Biotechnol Bioeng. 2015. Oct;112(10):2068–83. doi: 10.1002/bit.25615 [DOI] [PubMed] [Google Scholar]
  • 38.Valente KN, Levy NE, Lee KH, Lenhoff AM. Applications of proteomic methods for CHO host cell protein characterization in biopharmaceutical manufacturing. Curr Opin Biotechnol. 2018. Oct;53:144–50. doi: 10.1016/j.copbio.2018.01.004 [DOI] [PubMed] [Google Scholar]
  • 39.Tscheliessnig AL, Konrath J, Bates R, Jungbauer A. Host cell protein analysis in therapeutic protein bioprocessing—methods and applications. Biotechnol J. 2013. Jun;8(6):655–70. doi: 10.1002/biot.201200018 [DOI] [PubMed] [Google Scholar]
  • 40.Hogwood CEM, Bracewell DG, Smales CM. Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses. Curr Opin Biotechnol. 2014. Dec;30:153–60. doi: 10.1016/j.copbio.2014.06.017 [DOI] [PubMed] [Google Scholar]
  • 41.Levy NE, Valente KN, Lee KH, Lenhoff AM. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification. Biotechnol Bioeng. 2016. Jun;113(6):1260–72. doi: 10.1002/bit.25882 [DOI] [PubMed] [Google Scholar]
  • 42.Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized ppb-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26: 1367–1372. doi: 10.1038/nbt.1511 [DOI] [PubMed] [Google Scholar]
  • 43.Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of proteomics data. Nat Methods. 2016;13: 731–740. doi: 10.1038/nmeth.3901 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Vasu D Appanna

4 Mar 2022

PONE-D-21-40475Conversion of mammalian cell culture media waste to microbial fermentation feed efficiently supports production of recombinant protein by Escherichia coliPLOS ONE

Dear Dr, O'Connell

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses all the points raised during review process. It is important to comment on the choice of culture media utilized and the impact of the antibiotics on microbial physiology. Is the efficacy of the antibiotics diminished in the spent fluids? Please submit your revised manuscript by Apr 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Vasu D. Appanna

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors wish to thank Science Foundation Ireland and the EPSRC for joint funding of Ms Ciara Lynch through the Centre for Doctoral Training – Atoms to Products. The A2P CDT is supported by the Science Foundation Ireland (SFI) and the Engineering and Physical Sciences Research Council (EPSRC) under Grant No. 18/EPSRC-CDT/3582. The work was also supported by the Science Foundation Ireland funded BiOrbic bioeconomy research centre under grant no. 16/RC/3889.”

Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“CL & DO'C are funded by Science Foundation Ireland (SFI) and the Engineering and Physical Sciences Research Council (EPSRC) under Grant No. 18/EPSRC-CDT/3582.

CL & DO'C are funded by Science Foundation Ireland funded BiOrbic bioeconomy research centre under grant no. 16/RC/3889.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

4. Thank you for stating the following financial disclosure:

“CL & DO'C are funded by Science Foundation Ireland (SFI) and the Engineering and Physical Sciences Research Council (EPSRC) under Grant No. 18/EPSRC-CDT/3582.

CL & DO'C are funded by Science Foundation Ireland funded BiOrbic bioeconomy research centre under grant no. 16/RC/3889.”         

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a very interesting study demonstrating the conversion of mammalian cell culture waste to microbial fermentation feed, promoting bacterial growth and recombinant protein production. The authors further found that spent media would upregulate protein synthesis machinery enzymes but downregulate carbohydrate metabolism enzymes. The authors proposed that this approach can begin a route for the capture of a bioprocessing waste stream for the circular bioeconomy. Although this is an interesting topic for the readership of the journal, a significant revision is needed. Below are more detailed comments that need to be addressed.

The culture of mammalian cells are often maintained at 37˚C with 5% CO2 and atmospheric concentration of O2 (21%). It is not clear why this study used 95% O2 instead.

One more, normal culture of mammalian cells needs 10-20% serum, however in this study, serum-free medium was used throughout the whole process.

Some basic information on the spent media needs to be provided, such as pH, with phenol red or not, glucose level, ..

Statistics analysis was missing in all figures.

In the supplemental materials, only upregulated protein synthesis machinery enzymes were listed. It is suggested to list the downregulated carbohydrate metabolism enzymes as well.

Reviewer #2: The idea of ​​using the waste of a cell culture medium as a medium for the growth of bacteria such as the case of E. coli to produce proteins of interest is original and scientifically interesting. The manuscript is very well written. Just a few comments that need to be clarified by the authors before publication.

- The use of antibiotics is often indicated in cell culture media. Residues of these antibiotics present in waste cell culture media could inhibit bacterial growth. In the experimental section of this study, the authors used ampicillin at 100 µg/mL in the culture medium of E. coli but not in the culture medium of the CHO cell line. Could you clarify.

- Do you have an idea of ​​the degree of purity of target proteins in the two types of culture media?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 May 4;17(5):e0266921. doi: 10.1371/journal.pone.0266921.r002

Author response to Decision Letter 0


14 Mar 2022

Dear Dr Appanna,

We thank you and the reviwers for the positive review of our manuscript “Conversion of mammalian cell culture media waste to microbial fermentation feed efficiently supports production of recombinant protein by Escherichia coli”, tracking number PONE-D-21-40475. We have addressed the review comments and have provided a point by point response below.

Editor’s comments:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. We have made style changes as requested, including changes to reference formatting and author affiliations, addition of continuous line numbering, and removal of figures for inclusion as separate file elements.

2. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. The funding information has been deleted from the Acknowledgements section of the manuscript. We wish to amend our Funding Statement to the following: “CL & DO'C are funded by the centre for doctoral training, Atoms-2-Products. The A2P CDT is supported by the Science Foundation Ireland (SFI) and the Engineering and Physical Sciences Research Council (EPSRC) under Grant No. 18/EPSRC-CDT/3582. The work was also supported by the Science Foundation Ireland funded BiOrbic bioeconomy research centre under grant no. 16/RC/3889.”

3. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. The sentence in question refers to data that is not a core part of the research being presented and the phrase has been removed from the manuscript.

4. Please state what role the funders took in the study. The funders had no role in this study so please include the amended statement "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

5. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. The uncropped original gel result file has been added to our submission as the file S1_raw_images.pdf, and listed in the Supporting Information. The statement ‘Full image available as S1 file in Supporting Information.’ has been added to the text in the legend for figure 2.

6. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. We would like to add the following statement to our Data Availability Statement: “The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD026884.” We have also added this statement to our abstract: "Data is available via ProteomeXchange with identifier PXD026884." Submission details:

Project Name: E. coli BL21 Gold LC-MSMS in varying growth conditions

Project accession: PXD026884

Project DOI: Not applicable

Reviewer account details:

Username: reviewer_pxd026884@ebi.ac.uk

Password: RoWSbofL

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. Minimal data set has been added for the growth curve generation as supporting information, under file name S3_table.xlsx. Other minimal data sets are already present, under S2_table.xlsx and on the ProteomeXchange for the raw proteomic data.

Reviewers’ comments:

Reviewer 1:

1. The culture of mammalian cells are often maintained at 37˚C with 5% CO2 and atmospheric concentration of O2 (21%). It is not clear why this study used 95% O2 instead. Thank you for identifying this error in our Experimental Procedures section, which did not correctly indicate that atmospheric concentration of O2 (21%) was used. We have adjusted the text to now read ‘Chinese Hamster Ovary (CHO) cells were incubated in 20 ml of serum-free CHOgro® Expression media supplemented with 4 mM L-Glutamine in T75 adherent cell line flasks, at 37˚C with 5% CO2.’.

2. One more, normal culture of mammalian cells needs 10-20% serum, however in this study, serum-free medium was used throughout the whole process. A sentence and new citation have been added to our introduction explaining the usage of serum-free medium in bioprocess industry along with appropriate citation as follows ‘The formulation of chemically defined media used to culture stable cell lines in bioprocesses has been designed to remove the need for serum addition to achieve optimal cell growth and facilitate the purification of the expressed protein [3]. The regulations surrounding the bioprocessing of therapeutic proteins for drug use requires defined media without the addition of animal ingredients that cannot be fully standardised.’

3. Some basic information on the spent media needs to be provided, such as pH, with phenol red or not, glucose level. A sentence has been added to the Experimental Procedures stating ‘The pH of the spent media was generally > 7.5 post-culture and this was adjusted to pH 7 prior to use in bacterial fermentation with addition of dilute HCl. No other supplementation was added. Remaining glucose levels in the spent media after harvesting was 1.6%.’.

4. Statistics analysis was missing in all figures. Figure 1 contains standard deviation error bars from triplicate measurements stated in the figure legend as follows ‘All time points were completed in triplicate with standard deviation as error bars.’ We have also updated the legend with the following statement ‘Numerical data used to generate growth curves and standard deviations are reported in S3 table in Supporting Information.’. In panel A of Figure two we report standard deviations for duplicate measurements and is mentioned in the legend as follows ‘n = 2 for all standard deviation calculations.’. Figures 3 and 4 report data after a student’s t-test with a false discovery rate of <0.05 as stated in the figure legends. All of these statistical methods are described in the Experimental Procedures.

5. In the supplemental materials, only upregulated protein synthesis machinery enzymes were listed. It is suggested to list the downregulated carbohydrate metabolism enzymes as well. The supplemental material S2_table is a table of host cell proteins from CHO cell culture detected by mass spectrometry analysis of spent media alone prior to use as a bacterial fermentation feed. This provides detail on the protein content of the spent media as a feed. We have updated the text in the discussion section as follows ‘Mass spectrometry analysis of the CDSM alone identified 879 host cell proteins from CHO in the spent media after culturing (see Table S2).’.The proteomic analysis of E.coli dysregulated proteins including the protein synthesis machinery enzymes and the carbohydrate metabolism enzymes are included as raw data on the ProteomeXchange database with identifier PXD026884. The most significantly upregulated and downregulated proteins involved in protein synthesis and carbohydrate metabolism are shown in table 1 in the main manuscript.

Reviewer 2:

1. The use of antibiotics is often indicated in cell culture media. Residues of these antibiotics present in waste cell culture media could inhibit bacterial growth. In the experimental section of this study, the authors used ampicillin at 100 µg/mL in the culture medium of E. coli but not in the culture medium of the CHO cell line. Could you clarify. We have added a paragraph into our introduction to clarify this as follows ‘Additionally, stable cell line clones for the expression of commercial proteins relies on genomic integration of the target protein producing genes rather than transient expression from plasmid constructs. This removes the requirement for selective pressure from added antibiotics to maintain plasmid constructs.’.

2. Do you have an idea of the degree of purity of target proteins in the two types of culture media? In figure 2 panel B, the SDS gel with the pre-purified and post-purified protein fractions loaded on lanes 3 and 5 respectively shows a purification of approximately 95% post-size exclusion chromatography which was the typical result from either media type.

We have also added a new reference to our bibliography cited as reference [3] and have updated the order of the citations accordingly.

We hope that with these responses our manuscript may now be published in PLOS ONE. Thank you very much for this review.

Ciara Lynch and David O’Connell

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Vasu D Appanna

30 Mar 2022

Conversion of mammalian cell culture media waste to microbial fermentation feed efficiently supports production of recombinant protein by Escherichia coli

PONE-D-21-40475R1

Dear Dr. O'Connell

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Vasu D. Appanna

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have properly addressed my comments, I would like to suggest the manuscript to be accepted at this present version.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Noureddine Bouaïcha

Acceptance letter

Vasu D Appanna

14 Apr 2022

PONE-D-21-40475R1

Conversion of mammalian cell culture media waste to microbial fermentation feed efficiently supports production of recombinant protein by Escherichia coli

Dear Dr. O'Connell:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Vasu D. Appanna

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Raw images. Raw gel image for SDS-PAGE.

    PDF of uncropped gel image from Fig 2, panel B.

    (PDF)

    S1 Table. Table of CHO host cell proteins detected by LC-MS/MS in a spent CHOgro® media sample.

    Completed in triplicate with mean LFQ values displayed in third column.

    (XLSX)

    S2 Table. Table of numerical data used to generate growth curves and standard deviations.

    Completed in triplicate. Corresponds to growth curves generated for Fig 1.

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD026884. Submission details: Project Name: E. coli BL21 Gold LC-MSMS in varying growth conditions Project accession: PXD026884.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES